TEL-AVIV, Israel, Oct. 31, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary formulations and combinations of existing drugs, today announced that Adi Frish, RedHill’s Senior VP Business Development and Licensing, will present an overview of the Company at the 19th Annual Bio-Europe International Partnering Conference, on Tuesday, November 5, 2013, at 8:45 a.m. CET at the Messe Wien Exhibition and Congress Center in Vienna, Austria.
Help employers find you! Check out all the jobs and post your resume.
